ZBH (Zimmer Biomet Holdings) מכפיל EV/EBITDA

Zimmer Biomet Holdings (ZBH) relies on high surgeon loyalty to its instruments, which minimizes pricing competition. However, staffing shortages in clinics and pressure on product costs are constraining profits. The company is currently benefiting from pent-up demand among elderly patients. The EV/EBITDA multiple, accounting for operating profit and amortization, confirms these trends, where 10.51 is the current value of the indicator.

EV/EBITDA determines the total enterprise value of a business relative to its operating profit before depreciation and interest. This metric combines market capitalization with net debt, eliminating the influence of tax regimes and financing structures. The EV/EBITDA trend for this heavy-industry business helps identify deviations of the market price from the fundamental value of the assets. For Zimmer Biomet Holdings (ZBH), this reflects the integration efficiency of ROSA robotic systems and implants into surgical practice.